Global Butterfly Needle Set Market Overview
As per MRFR analysis, the Butterfly Needle Set Market Size was estimated at 0.76 (USD Billion) in 2022.
The Butterfly Needle Set Market is expected to grow from 0.79 (USD Billion) in 2023 to 1.1 (USD Billion) by 2032. The Butterfly Needle Set Market CAGR (growth rate) is expected to be around 3.77% during the forecast period (2024 - 2032).
Key Butterfly Needle Set Market Trends Highlighted
Butterfly needle sets, designed for intravenous and subcutaneous injections, are gaining prominence in healthcare settings. Driven by the increasing prevalence of chronic diseases and the growing need for minimally invasive procedures, the butterfly needle set market is poised for significant growth in the coming years.
The rising demand for precision in drug delivery and patient comfort is fueling the adoption of butterfly needle sets, which offer accurate injections and reduce discomfort compared to traditional needles.
Technological advancements, such as the development of safety features like needle shields and ergonomic designs, are also driving market growth. Moreover, the growing use of butterfly needle sets in home and ambulatory care settings provides significant opportunities for market expansion.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Butterfly Needle Set Market Drivers
Increasing Prevalence of Chronic Diseases
Chronic diseases such as diabetes, cancer, and kidney disease are on the rise globally. These conditions often require frequent blood draws and injections, which has led to an increased demand for butterfly needle sets.
Butterfly needles are less painful and easier to use than traditional needles, making them an ideal choice for patients who require frequent blood draws or injections. The increasing prevalence of chronic diseases is a major factor driving the growth of the butterfly needle set market.
Growing Demand for Minimally Invasive Procedures
Minimally invasive procedures are becoming increasingly popular as they offer a number of advantages over traditional open surgery. These procedures require the use of smaller needles and incisions, which has created a demand for butterfly needle sets.
Butterfly needles are ideal for minimally invasive procedures because they are less traumatic and reduce the risk of complications. The growing demand for minimally invasive procedures is another major factor driving the growth of the butterfly needle set market.
Technological Advancements
Technological advancements are also contributing to the growth of the butterfly needle set market. The development of new needle designs and materials has made butterfly needles more effective and easier to use.
For example, some butterfly needles are now coated with a special lubricant that reduces pain during insertion. Other butterfly needles are designed with a safety feature that prevents accidental needle sticks. These technological advancements are making butterfly needle sets more attractive to patients and healthcare professionals.
Butterfly Needle Set Market Segment Insights:
Butterfly Needle Set Market Needle Gauge Insights
The Needle Gauge segment of the Butterfly Needle Set Market is categorized into 19G, 21G, 23G, 25G, and 27G. Among these, the 23G segment is projected to dominate the market, accounting for a revenue share of around 35% in 2024.
This dominance can be attributed to the widespread use of 23G needles in various clinical applications, including blood collection, injections, and IV therapy. Furthermore, the growing demand for minimally invasive procedures is expected to fuel the demand for 23G butterfly needles. The 25G segment is anticipated to witness a steady growth rate over the forecast period.
The increasing prevalence of chronic diseases, such as diabetes and anemia, is driving the demand for frequent blood draws. As 25G needles are commonly used for these procedures, the segment is expected to benefit from this trend.
The 19G and 21G segments are also projected to experience significant growth, owing to their suitability for larger blood draws and injections. These needles are often used in emergency situations, blood transfusions, and the administration of medications that require higher flow rates. The 27G segment is expected to account for a smaller share of the market compared to the other segments.
This can be attributed to its limited use in specific applications, such as pediatric care and fragile veins. However, the segment is expected to witness a stable growth rate due to its advantages in minimizing pain and discomfort during injections.
Overall, the Needle Gauge segment of the Butterfly Needle Set Market is expected to exhibit steady growth over the coming years, driven by the increasing demand for minimally invasive procedures, the rising prevalence of chronic diseases, and the growing adoption of advanced healthcare technologies.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Butterfly Needle Set Market Material Insights
The Butterfly Needle Set Market is segmented by Material into Stainless Steel, Polypropylene, and Polyethylene. The Stainless-Steel segment holds the largest market share due to its durability, corrosion resistance, and ability to withstand repeated sterilization.
The Polypropylene segment is expected to grow at a significant rate due to its low cost, lightweight, and flexibility. The market growth is attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and growing awareness about the benefits of butterfly needle sets.
Butterfly Needle Set Market Safety Mechanism Insights
The Safety Mechanism segment plays a crucial role in the Butterfly Needle Set Market, offering distinct features and benefits to healthcare professionals. Retractable Needle and Non-Retractable Needle are the two primary types of Safety Mechanisms available in the market.
Retractable Needle sets feature a protective sheath that automatically covers the needle after use, reducing the risk of needlestick injuries for healthcare workers. Non-Retractable Needle sets, on the other hand, do not have a retractable mechanism, making them more cost-effective but posing a higher risk of accidental needle sticks.
In 2023, the Retractable Needle segment held the dominant share in the Butterfly Needle Set Market revenue, accounting for approximately 60%. The growing emphasis on safety in healthcare settings and government regulations mandating the use of safety-engineered medical devices have contributed to this dominance.
The Non-Retractable Needle segment is projected to witness a steady growth rate, primarily driven by its lower cost compared to Retractable Needles. The Butterfly Needle Set Market segmentation provides valuable insights into the market dynamics, enabling manufacturers to tailor their product offerings and strategies accordingly.
This data empowers stakeholders to make informed decisions and capitalize on growth opportunities within the industry.
Butterfly Needle Set Market Application Insights
The Application segment of the Butterfly Needle Set Market holds significant importance, influencing market growth and dynamics. Blood Collection, Intravenous Therapy, and Subcutaneous Injections are the key applications driving the market's expansion.
Blood Collection accounted for the largest revenue share in the Butterfly Needle Set Market in 2023, owing to its widespread use in medical facilities and laboratories for collecting blood samples for diagnostic purposes. The increasing prevalence of chronic diseases and the growing demand for regular blood monitoring contribute to the segment's growth.
Intravenous Therapy is another major application, accounting for a substantial market share. Butterfly needle sets are commonly used in hospitals, clinics, and home healthcare settings for administering intravenous fluids, medications, and nutrients directly into the bloodstream.
The rising incidence of infectious diseases and the increasing number of patients requiring intravenous treatment drive the segment's expansion. Subcutaneous Injections, used to deliver medications or fluids beneath the skin, also contribute to the Butterfly Needle Set Market growth.
This application is gaining traction due to the growing prevalence of diabetes, autoimmune disorders, and other conditions requiring self-administered injections.
Overall, the Application segment offers valuable insights into the specific end-uses of Butterfly Needle Sets, highlighting the key factors influencing demand and growth opportunities within the Butterfly Needle Set Market.
Butterfly Needle Set Market End User Insights
The Butterfly Needle Set Market is segmented by end user into hospitals and clinics, home healthcare, and veterinary clinics. Hospitals and clinics were the largest end user segment, accounting for over 60% of the global market revenue in 2023. The growth of this segment is attributed to the increasing number of surgeries and invasive procedures performed in hospitals and clinics.
Home healthcare is likely to be the fastest-growing end user segment, with a projected CAGR of over 4% from 2024 to 2032. This growth is driven by the rising demand for home healthcare services, such as infusion therapy and blood transfusions, due to the increasing prevalence of chronic diseases and the growing elderly population.
Veterinary clinics are a relatively small end user segment, but they are expected to experience steady growth over the forecast period due to the increasing number of companion animals and the rising demand for veterinary care.
Butterfly Needle Set Market Regional Insights
The Butterfly Needle Set Market is segmented into North America, Europe, APAC, South America, and MEA. North America held the largest share of the market in 2023 and is expected to continue to dominate the market throughout the forecast period.
The growth of the North American market is attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and favorable reimbursement policies. Europe is the second largest market for butterfly needle sets, with a significant presence of major manufacturers and a well-established healthcare system.
The APAC region is expected to witness the fastest growth over the forecast period, due to the increasing healthcare expenditure, rising population, and growing awareness of minimally invasive procedures. South America and MEA are expected to have a relatively smaller market share but are expected to grow steadily over the forecast period.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Butterfly Needle Set Market Key Players and Competitive Insights:
Major players in the Butterfly Needle Set Market are constantly striving to gain a competitive edge by investing in research and development, expanding their product portfolio, and acquiring smaller players.
Leading Butterfly Needle Set Market players are focusing on developing innovative products that cater to the specific needs of end-users, such as those with diabetes or other chronic conditions that require frequent injections.
The Butterfly Needle Set Market development is also being driven by the increasing adoption of home healthcare services, which is leading to a growing demand for disposable and easy-to-use medical devices.
The competitive Landscape of Butterfly Needle Set Market is expected to remain highly competitive in the coming years, with major players continuing to invest in new technologies and products to maintain their market share.
Becton, Dickinson and Company is a leading medical technology company that manufactures and markets a wide range of medical devices, including Butterfly Needle Set. The company has a strong presence in the Butterfly Needle Set Market, with a wide distribution network and a strong brand reputation.
Becton, Dickinson and Company is known for its high-quality products and its commitment to innovation. The company is also actively involved in research and development, and it has a number of new products in the pipeline that are expected to be launched in the coming years.
Terumo Medical Corporation is another major player in the Butterfly Needle Set Market. The company manufactures and markets a wide range of medical devices, including blood transfusion sets, IV therapy sets, and Butterfly Needle Set.
Terumo Medical Corporation has a strong presence in the Butterfly Needle Set Market, with a wide distribution network and a strong brand reputation. The company is known for its high-quality products and its commitment to customer service.
Terumo Medical Corporation is also actively involved in research and development, and it has a number of new products in the pipeline that are expected to be launched in the coming years.
Key Companies in the Butterfly Needle Set Market Include:
- Smiths Medical
- Steris Corporation
- Medtronic plc
- Terumo Corporation
- Halyard Health, Inc.
- Nipro Corporation
- Fresenius Kabi AG
- EKF Diagnostics Holdings plc
- Braun Melsungen AG
- Cardinal Health
- Owen Mumford Ltd.
- Baxter International Inc.
- Becton, Dickinson and Company (BD)
- Merit Medical Systems, Inc.
Butterfly Needle Set Market Developments
The increasing prevalence of chronic diseases, such as diabetes, and the growing adoption of minimally invasive procedures are key factors driving market growth.
The rising geriatric population and the increasing demand for home healthcare services are also contributing to the market expansion. Furthermore, technological advancements, such as the development of atraumatic needles and safety features, are expected to propel market growth in the coming years.
Key players in the market include Becton, Dickinson and Company, Terumo Corporation, Smiths Medical, and Nipro Corporation. In 2023, the market was valued at USD 0.79 billion.
Butterfly Needle Set Market Segmentation Insights
Butterfly Needle Set Market Needle Gauge Outlook
Butterfly Needle Set Market Material Outlook
- Stainless Steel
- Polypropylene
- Polyethylene
Butterfly Needle Set Market Safety Mechanism Outlook
- Retractable Needle
- Non-Retractable Needle
Butterfly Needle Set Market Application Outlook
- Blood Collection
- Intravenous Therapy
- Subcutaneous Injections
Butterfly Needle Set Market End User Outlook
- Hospitals and Clinics
- Home Healthcare
- Veterinary Clinics
Butterfly Needle Set Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
0.76(USD Billion) |
| Market Size 2023 |
0.79(USD Billion) |
| Market Size 2032 |
1.1(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
3.77% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
Smiths Medical, Steris Corporation, Medtronic plc, Terumo Corporation, Halyard Health, Inc., Nipro Corporation, Fresenius Kabi AG, EKF Diagnostics Holdings plc, Braun Melsungen AG, Cardinal Health, Owen Mumford Ltd., Baxter International Inc., Becton, Dickinson and Company (BD), Merit Medical Systems, Inc. |
| Segments Covered |
Needle Gauge, Material, Safety Mechanism, Application, End User, Regional |
| Key Market Opportunities |
Growing demand for minimally invasive procedures Increasing prevalence of chronic diseases Expansion into emerging markets Technological advancements Rising healthcare expenditure |
| Key Market Dynamics |
Technological advancements Rising awareness of safety Increasing prevalence of chronic diseases Expanding healthcare infrastructure Growth in disposable income |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Global Butterfly Needle Set Market size was around USD 0.79 Billion in 2023.
The Global Butterfly Needle Set Market is expected to grow at a CAGR of 3.77% from 2024 to 2032.
The increasing demand for minimally invasive procedures and the growing prevalence of chronic diseases are the key factors driving the growth of the Global Butterfly Needle Set Market.
North America and Europe are the major regions contributing to the growth of the Global Butterfly Needle Set Market.
Some of the key competitors in the Global Butterfly Needle Set Market are Becton, Dickinson and Company, Terumo Corporation, and Smiths Medical.
Butterfly Needle Sets are primarily used for blood collection, injections, and intravenous therapy.
The Global Butterfly Needle Set Market is expected to reach a value of USD 1.1 Billion by 2032.
The major challenge faced by the Global Butterfly Needle Set Market is the availability of alternative blood collection and injection devices.
